AstraZeneca reported $3.32B in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Alcon AG ALC:SW USD 299M 184M
Amgen AMGN:US USD 3.04B 460M
AstraZeneca AZN:LN USD 3.32B 283M
AstraZeneca AZN:SS USD 3.32B 283M
Astrazeneca AZN:US USD 3.32B 283M
Bayer BAYN:GR EUR 5.78B 3.33B
Biogen BIIB:US USD 998.8M 6M
Bristol Myers Squibb BMY:US USD 4.66B 663M
Fresenius FRE:GR EUR 2.12B 505M
Fresenius Medical Care FME:GR EUR 1.13B 317.14M
Galapagos GLPG:NA EUR -110752000 79.05M
Gilead Sciences GILD:US USD 2.7B 662M
GlaxoSmithKline GSK:LN GBP 1.6B 1.76B
Hikma Pharmaceutical HIK:LN USD 350M 1000K
Lonza Group LONN:SW CHF 1.21B 220M
Merck MRK:GR EUR 1.63B 178M
Novartis NOVN:VX USD 4.5B 193M
Pfizer PFE:US USD 6.94B 3.94B
Philips PHIA:NA EUR 929M 299M
Recordati REC:IM EUR 162.47M 7.47M
Roche Holding ROG:VX 10.43B 3B